Viral hepatitis

Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides: A 12-Year Experience.

Chang M, Olsen S, Pichardo E, Stiles J, Rosenthal-Cogan L, Brubaker W, et al. Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides: A 12-Year Experience. //Transplantation. 2013;95(7):960-965.